Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 615

1.

Type 1 diabetes: chronic progressive autoimmune disease.

Zhang L, Gianani R, Nakayama M, Liu E, Kobayashi M, Baschal E, Yu L, Babu S, Dawson A, Johnson K, Jahromi M, Aly T, Fain P, Barker J, Rewers M, Eisenbarth GS.

Novartis Found Symp. 2008;292:85-94; discussion 94-8, 122-9, 202-3.

PMID:
19203094
2.

Insulin autoimmunity: immunogenetics/immunopathogenesis of type 1A diabetes.

Eisenbarth GS.

Ann N Y Acad Sci. 2003 Nov;1005:109-18.

PMID:
14679045
3.

The natural history of type 1A diabetes.

Eisenbarth GS, Jeffrey J.

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):146-55. Review.

4.

Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.

Dotta F, Eisenbarth GS.

Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 2):S85-95. Review.

PMID:
2642771
5.

Insulin autoimmunity: prediction/precipitation/prevention type 1A diabetes.

Eisenbarth GS, Moriyama H, Robles DT, Liu E, Yu L, Babu S, Redondo MJ, Gottlieb P, Wegmann D, Rewers M.

Autoimmun Rev. 2002 May;1(3):139-45. Review. Erratum in: Autoimmun Rev. 2006 May;5(5):364. Redondo, Maria [corrected to Redondo, Maria J].

PMID:
12849007
6.

Insulin-specific tolerance in diabetes.

Gottlieb PA, Eisenbarth GS.

Clin Immunol. 2002 Jan;102(1):2-11. Review.

PMID:
11781061
7.

Role of autoantibodies in type 1 diabetes.

Miao D, Yu L, Eisenbarth GS.

Front Biosci. 2007 Jan 1;12:1889-98. Review.

PMID:
17127428
8.

The stages of type 1A diabetes: 2005.

Gianani R, Eisenbarth GS.

Immunol Rev. 2005 Apr;204:232-49. Review.

PMID:
15790362
9.

Immunopathogenesis and immunotherapeutic approaches to type 1A diabetes.

Azam A, Eisenbarth GS.

Expert Opin Biol Ther. 2004 Oct;4(10):1569-75. Review.

PMID:
15461568
10.

[Autoimmunity and insulin-dependent diabetes mellitus. Experimental data and therapeutic prospects].

Thivolet C, Khallouf E.

Pediatrie. 1989;44(4):247-57. Review. French.

PMID:
2677968
11.
12.

The stages of type 1A diabetes.

Babaya N, Nakayama M, Eisenbarth GS.

Ann N Y Acad Sci. 2005 Jun;1051:194-204. Review.

PMID:
16126959
13.

Insulin autoantibodies are associated with islet inflammation but not always related to diabetes progression in NOD congenic mice.

Robles DT, Eisenbarth GS, Dailey NJ, Peterson LB, Wicker LS.

Diabetes. 2003 Mar;52(3):882-6.

14.

B cells in the spotlight: innocent bystanders or major players in the pathogenesis of type 1 diabetes.

Silveira PA, Grey ST.

Trends Endocrinol Metab. 2006 May-Jun;17(4):128-35. Epub 2006 Apr 3. Review.

PMID:
16580840
15.

Genetic and immunological basis of autoimmune diabetes in the NOD mouse.

Yoshida K, Kikutani H.

Rev Immunogenet. 2000;2(1):140-6. Review.

PMID:
11324686
16.

Specificity of islet cell autoantibodies and coexistence with other organ specific autoantibodies in type 1 diabetes mellitus.

Tsirogianni A, Pipi E, Soufleros K.

Autoimmun Rev. 2009 Jul;8(8):687-91. doi: 10.1016/j.autrev.2009.02.019. Epub 2009 Feb 13. Review.

PMID:
19217947
17.

Autoimmunity triggers in the NOD mouse: a role for natural auto-antibody reactivities in type 1 diabetes.

Côrte-Real J, Duarte N, Tavares L, Penha-Gonçalves C.

Ann N Y Acad Sci. 2009 Sep;1173:442-8. doi: 10.1111/j.1749-6632.2009.04661.x.

PMID:
19758184
18.

Immune mechanisms leading to type 1 insulin-dependent diabetes mellitus.

Boitard C, Timsit J, Larger E, Dubois D.

Horm Res. 1997;48 Suppl 4:58-63. Review.

PMID:
9350450
19.

Chronic autoimmunity of type I diabetes.

Simone E, Eisenbarth GS.

Horm Metab Res. 1996 Jul;28(7):332-6.

PMID:
8858379
20.

Development of new strategies to prevent type 1 diabetes: the role of animal models.

Hänninen A, Hamilton-Williams E, Kurts C.

Ann Med. 2003;35(8):546-63. Review.

PMID:
14708966

Supplemental Content

Support Center